Capsule Endoscopy Market Size, Share & Trends Analysis Report By Type (Small Bowel Capsule Endoscopy, Esophageal Capsule Endoscopy), By Application (OGIB (Obscure GI Tract Bleeding), Crohn’s Disease), By End Use, By Region, And Segment Forecasts, 2026 - 2
Description
Capsule Endoscopy Market Size & Trends
The global capsule endoscopy market size was estimated at USD 475.69 million in 2025 and is projected to reach USD 880.51 million by 2033, growing at a CAGR of 8.06% from 2026 to 2033. The increasing prevalence of Gastrointestinal (GI) diseases & colon cancer, rising demand for minimally invasive diagnostic procedures, and introduction of technologically advanced capsule endoscopes are the major factors driving the market.
For instance, according to the Canadian Cancer Society, colorectal cancer is expected to be the 4th most commonly diagnosed cancer in Canada in 2024. As per estimates provided by the Canadian Cancer Society, 25,200 Canadians were diagnosed with colorectal cancer, which represented 10% of all new cancer cases in 2024.
As awareness of the clinical benefits of capsule endoscopy, patient convenience, and diagnostic accuracy continues to rise, more hospitals and healthcare providers are incorporating capsule endoscopy into their gastroenterology services. This adoption is driven by the demand for minimally invasive diagnostic procedures, especially for conditions that are difficult to diagnose with traditional endoscopy. Hospitals are increasingly investing in capsule endoscopy technology as it provides detailed imaging of the entire small intestine. The following are the several hospitals that offer capsule endoscopy services
Global Capsule Endoscopy Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global capsule endoscopy market report based on type, application, end use, and region:
The global capsule endoscopy market size was estimated at USD 475.69 million in 2025 and is projected to reach USD 880.51 million by 2033, growing at a CAGR of 8.06% from 2026 to 2033. The increasing prevalence of Gastrointestinal (GI) diseases & colon cancer, rising demand for minimally invasive diagnostic procedures, and introduction of technologically advanced capsule endoscopes are the major factors driving the market.
For instance, according to the Canadian Cancer Society, colorectal cancer is expected to be the 4th most commonly diagnosed cancer in Canada in 2024. As per estimates provided by the Canadian Cancer Society, 25,200 Canadians were diagnosed with colorectal cancer, which represented 10% of all new cancer cases in 2024.
As awareness of the clinical benefits of capsule endoscopy, patient convenience, and diagnostic accuracy continues to rise, more hospitals and healthcare providers are incorporating capsule endoscopy into their gastroenterology services. This adoption is driven by the demand for minimally invasive diagnostic procedures, especially for conditions that are difficult to diagnose with traditional endoscopy. Hospitals are increasingly investing in capsule endoscopy technology as it provides detailed imaging of the entire small intestine. The following are the several hospitals that offer capsule endoscopy services
Global Capsule Endoscopy Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global capsule endoscopy market report based on type, application, end use, and region:
- Type Outlook (Unit Volume, In Thousand Units; Revenue, USD Million, 2021 - 2033)
- Small Bowel Capsule Endoscopy
- Esophageal Capsule Endoscopy
- Colon Capsule Endoscopy
- Others
- Application Outlook (Unit Volume, In Thousand Units; Revenue, USD Million, 2021 - 2033)
- OGIB (obscure GI tract bleeding)
- Crohn’s disease
- Small Intestine tumor
- Others (Celiac, NSAID reactions)
- End Use Outlook (Unit Volume, In Thousand Units; Revenue, USD Million, 2021 - 2033)
- Hospitals
- Outpatient Facilities
- Regional Outlook (Revenue, USD Million) (Unit Volume, In Thousand Units, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
150 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definition
- 1.2.1. Consumable
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.7. Primary Research
- 1.8. Information or Data Analysis
- 1.9. Market Formulation & Validation
- 1.10. Market Model
- 1.11. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Microcarriers Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. High demand of cell-based vaccines & therapeutics
- 3.2.1.2. Rising incidence of chronic diseases & disorders
- 3.2.1.3. Increasing investments for development of innovative therapies
- 3.2.1.4. Recent technological advancements in cell biology research
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of research for cell based drug and therapy
- 3.2.2.2. High cost of downstream processing
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
- Chapter 4. Microcarriers Market: Consumable Estimates & Trend Analysis
- 4.1. Consumable Movement Analysis & Market Share, 2025 & 2033
- 4.2. Microcarriers Market Estimates & Forecast, By Consumable, 2021 to 2033 (USD Million)
- 4.3. Media and Reagents
- 4.3.1. Media and Reagents Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4. Microcarrier Beads
- 4.4.1. Microcarrier Beads Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Collagen Coated Beads
- 4.4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Cationic Beads
- 4.4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Protein Coated Beads
- 4.4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.5. Untreated Beads
- 4.4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 4.4.6. Others
- 4.4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 5. Microcarriers Market: Application Estimates & Trend Analysis
- 5.1. Application Movement Analysis & Market Share, 2025 & 2033
- 5.2. Microcarriers Market Estimates & Forecast, By Application, 2021 to 2033 (USD Million)
- 5.3. Biopharmaceutical Production
- 5.3.1. Biopharmaceutical Production Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.2. Vaccine Production
- 5.3.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.3.3. Therapeutic Production
- 5.3.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 5.4. Regenerative Medicine
- 5.4.1. Regenerative Medicine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 6. Microcarriers Market: End Use Estimates & Trend Analysis
- 6.1. End Use Movement Analysis & Market Share, 2025 & 2033
- 6.2. Microcarriers Market Estimates & Forecast, By End Use, 2021 to 2033 (USD Million)
- 6.3. Pharmaceutical & Biotechnology Companies
- 6.3.1. Pharmaceutical & Biotechnology Companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.4. Contract Research Organizations (CRO)s & Contract Manufacturing Organizations (CMO)s
- 6.4.1. CROs & CMOs Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 6.5. Academic & Research Institutes
- 6.5.1. Academic & Research Institutes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- Chapter 7. Microcarriers Market: Regional Estimates & Trend Analysis by Consumable, Application and End Use
- 7.1. Regional Dashboard
- 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 7.3. North America
- 7.3.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Key country dynamics
- 7.3.2.2. Regulatory framework
- 7.3.2.3. Competitive scenario
- 7.3.2.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.3.3. Canada
- 7.3.3.1. Key country dynamics
- 7.3.3.2. Regulatory framework
- 7.3.3.3. Competitive scenario
- 7.3.3.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.3.4. Mexico
- 7.3.4.1. Key country dynamics
- 7.3.4.2. Regulatory framework
- 7.3.4.3. Competitive scenario
- 7.3.4.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4. Europe
- 7.4.1. Europe market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.2. UK
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.3. Germany
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.4. France
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive scenario
- 7.4.4.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.5. Italy
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Regulatory framework
- 7.4.5.3. Competitive scenario
- 7.4.5.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.6. Spain
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Regulatory framework
- 7.4.6.3. Competitive scenario
- 7.4.6.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.7. Denmark
- 7.4.7.1. Key country dynamics
- 7.4.7.2. Regulatory framework
- 7.4.7.3. Competitive scenario
- 7.4.7.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.8. Sweden
- 7.4.8.1. Key country dynamics
- 7.4.8.2. Regulatory framework
- 7.4.8.3. Competitive scenario
- 7.4.8.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.4.9. Norway
- 7.4.9.1. Key country dynamics
- 7.4.9.2. Regulatory framework
- 7.4.9.3. Competitive scenario
- 7.4.9.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5. Asia Pacific
- 7.5.1. Asia Pacific market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.2. Japan
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.3. China
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.4. India
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.5. Australia
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.5.7. Thailand
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6. Latin America
- 7.6.1. Latin America market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.2. Brazil
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7. MEA
- 7.7.1. MEA market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.3. Saudi Arabia
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.4. UAE
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework
- 7.7.4.3. Competitive scenario
- 7.7.4.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
- 7.7.5. Kuwait
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework
- 7.7.5.3. Competitive scenario
- 7.7.5.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Key company market position analysis, 2025
- 8.3. Company Overview
- 8.3.1. Thermo Fisher Scientific, Inc.
- 8.3.1.1. Company overview
- 8.3.1.2. Financial performance
- 8.3.1.3. Product benchmarking
- 8.3.1.4. Strategic initiatives
- 8.3.2. Merck KGaA
- 8.3.2.1. Company overview
- 8.3.2.2. Financial performance
- 8.3.2.3. Product benchmarking
- 8.3.2.4. Strategic initiatives
- 8.3.3. Danaher Corporation
- 8.3.3.1. Company overview
- 8.3.3.2. Financial performance
- 8.3.3.3. Product benchmarking
- 8.3.3.4. Strategic initiatives
- 8.3.4. Sartorius AG
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Corning Incorporated
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Eppendorf SE
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Bio-Rad Laboratories, Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. HiMedia Laboratories Pvt. Ltd.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. DenovoMATRIX GmbH
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
